The U. S. Food and Drug Administration (FDA) has a need for the procurement to recruit patients who were diagnosed with mild or moderate traumatic brain injury within 6 months, who are experiencing chronic pain requiring consistent pain control medications, and who are diagnosed with Parkinson's disease for a Dysfunctions Patient Study.